Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Myovant Sciences Ltd. (MYOV)  
$26.98 0.00 (0.00%) as of 4:30 Thu 3/9


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 90,590,000
Market Cap: 2.44(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $26.98 - $26.98
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Myovant Sciences is a biopharmaceutical company. Co. has two U.S. Food and Drug Administration-approved products, which consist of: ORGOVYX® (relugolix 120 mg), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with prostate cancer; and MYFEMBREE® (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg), an oral GnRH treatment for the management of heavy menstrual bleeding associated with uterine fibroids. Co.'s MYFEMBREE is being evaluated for contraceptive ability in women with heavy menstrual bleeding associated with uterine fibroids or endometriosis-associated pain who are 18 to 50 years of age and at risk for pregnancy.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 51,599,200
Total Buy Value $0 $0 $0 $1,393,178,400
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 0 0 0 107,215
Total Sell Value $0 $0 $0 $2,154,122
Total People Sold 0 0 0 5
Total Sell Transactions 0 0 0 22
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 186
  Page 7 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-04-08 4 AB $8.53 $596,939 I/I 70,000 47,208,604 115%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-04-07 4 AB $8.21 $574,364 I/I 70,000 47,138,604 137%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-04-06 4 AB $8.44 $590,520 I/I 70,000 47,068,604 97%     
   Sablich Kim Chief Commercial Officer   •       –      –    2020-04-03 4 A $0.00 $0 D/D 87,805 146,710     -
   Karbe Frank Principal Finl & Accounting   •       –      –    2020-04-03 4 A $0.00 $0 D/D 120,146 163,470     -
   Lang Matthew General Counsel & Corp. Secy.   •       –      –    2020-04-03 4 A $0.00 $0 D/D 111,268 145,865     -
   Seely Lynn Principal Executive Officer   •       •      –    2020-04-03 4 A $0.00 $0 D/D 197,659 1,043,824     -
   Ferreira Juan Camilo Arjona Chief Medical Officer   •       –      –    2020-04-03 4 A $0.00 $0 D/D 87,805 145,115     -
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-04-03 4 AB $7.93 $554,925 I/I 70,000 46,998,604 116%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-04-02 4 AB $7.73 $541,086 I/I 70,000 46,928,604 117%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-04-01 4 AB $7.46 $522,298 I/I 70,000 46,858,604 105%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-03-31 4 AB $7.97 $557,984 I/I 70,000 46,788,604 100%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-03-30 4 AB $7.65 $535,766 I/I 70,000 46,718,604 94%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-03-27 4 AB $7.98 $558,250 I/I 70,000 46,648,604 93%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-03-26 4 AB $7.94 $555,807 I/I 70,000 46,578,604 98%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-03-25 4 AB $7.60 $821,895 I/I 108,100 46,508,604 113%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-03-24 4 AB $7.67 $1,620,559 I/I 211,200 46,400,504 111%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-03-23 4 AB $7.68 $1,621,932 I/I 211,200 46,189,304 103%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-03-20 4 AB $7.60 $1,472,709 I/I 193,900 45,978,104 108%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-03-19 4 AB $7.68 $1,488,958 I/I 193,900 45,784,204 101%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-03-18 4 AB $7.40 $1,434,938 I/I 193,900 45,590,304 129%     
   Sablich Kim Chief Commercial Officer   •       –      –    2020-03-18 4 S $6.93 $5,787 D/D (785) 58,905 -129%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-03-17 4 AB $7.40 $1,433,949 I/I 193,900 45,396,404 130%     
   Sumitovant Biopharma Ltd. 10% Owner   –       –       •   2020-03-16 4 AB $7.25 $1,406,008 I/I 193,900 45,202,504 155%     
   Sablich Kim Chief Commercial Officer   •       –      –    2020-01-15 4 AS $14.04 $67,954 D/D (4,840) 59,690 -10%     
  186 Records found
  1  2  3  4  5  6  7  8   
  Page 7 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us